Management and administration of pharmacy reimbursement programs; Managing and administering the distribution of prescription pharmaceutical samples to physicians and patients for pharmaceutical manufacturers; Management and administration of patient co-pay reimbursement programs on behalf of pharmaceutical manufacturers; Management and administration of financial assistance programs that provide patients with access to affordable medicine; Management and administration of patient support programs for pharmaceutical manufacturers; Management and administration of patient engagement programs for pharmaceutical manufacturers; Management and administration of formulary, patient, and payer policy information for pharmaceutical, medical device, and diagnostic manufacturers; Management and administration of educational engagements for Health Care Providers, namely, educating healthcare providers on medications, disease status and standard of care; Management of the distribution of clinical trial medication and supplies on behalf of pharmaceutical manufacturers; Tracking pharmaceutical promotional programs for pharmaceutical manufacturers and evaluating and determining their effectiveness; Data management services in the field of pharmaceutical patient safety, namely, collecting adverse events data, storing the data, and reporting collected adverse events data; Patient support services, namely, enrolling patients of pharmaceutical manufacturers in support programs that enables the patients to view, track and manage the support program wherein the patient support program provides pharmaceutical product and medication education, medication adherence support, visibility into medication delivery and case status, clinical support services including injection and product educational training, access to financial assistance programs, payer coverage status updates, patient engagement services and reminders and notifications; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturers, namely, promoting awareness of diseases, pharmaceutical brands, and treatment affordable options; Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturers, namely, marketing services in the nature of promotion of pharmaceutical manufacturers and disease treatment options via social media; Tracking payer coverage policies and related documentation and providing life sciences clients access to such in order to enhance their market access strategies and patient support programs; Life science strategy consulting services for assisting clients with commercial assessments, corporate and portfolio strategy, new product planning and commercialization support, and pricing and market access insights

Payment services, namely, reimbursement payment processing in the field of pharmaceutical financial assistance programs and loyalty program payment processing services provided on behalf of pharmaceutical manufacturers for the purpose of delivering benefits to patients enrolled in pharmaceutical manufacturer-sponsored financial assistance programs; Pharmacy benefit manager (PBM) accumulator mitigation services and detecting claim activity indicative of a pharmacy benefit manager attempting to abuse the use of co-pay cards by not applying amounts paid by clients towards the patient's deductible or annual out-of-pocket expense; Anti-kickback and risk mitigation services for the pharmaceutical industry, namely, antikickback compliance services for assuring that patients who have full or partial federally funded drug coverage are excluded from utilizing co-pay cards

Outbound healthcare provider engagement services provided on behalf of pharmaceutical manufacturers, namely, providing podcasts, seminars, workshops, virtual and in-person presentations in the field of diseases, pharmaceutical brands, and affordable healthcare options

Quality assurance and quality control patient claim services for monitoring paid claims to patients from insurance or pharmaceutical entities to insure that specific business rules are being correctly applied to patient claims; Pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Pharmacovigilance services for others, namely, monitoring the quality of efficacy of pharmaceutical preparations

Legislative update services and updating legal and regulatory issues within the co-pay or patient affordability space; Pharmacy fraud monitoring services